Donepezil Hcl
Rank #256 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$50.3M
Total Cost
3,178,215
Total Claims
$50.3M
Total Cost
53,121
Prescribers
$16
Cost per Claim
564,203
Beneficiaries
5,285,940
30-Day Fills
$948
Avg Cost/Provider
60
Avg Claims/Provider
Share of Medicare Part D Spending
0.02%
of total Medicare Part D spending
$50.3M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $50.3M total
🔎 Data Overview
At $16.00 per prescription, this is an affordable generic medication. Wider use of affordable generics like this could save Medicare billions annually.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Top Prescribers of Donepezil Hcl
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Idan Sharon | Neurology | Brooklyn, NY | 167 | $85K |
| 2 | Terence Frinks | Family Practice | Tucker, GA | 4,293 | $48K |
| 3 | Donald Vollmer | Family Practice | Hendersonville, TN | 3,619 | $44K |
| 4 | Fernando Gonzales-Portillo | Internal Medicine | Orlando, FL | 3,169 | $41K |
| 5 | Jose Soria-Lopez | Neurology | San Diego, CA | 956 | $36K |
| 6 | Arutyun Topsakalyan | General Practice | Glendale, CA | 2,204 | $36K |
| 7 | Maria Wiscovitch | Neurology | Fajardo, PR | 709 | $34K |
| 8 | Daniel Miller | Internal Medicine | Columbus, OH | 1,818 | $34K |
| 9 | Antoine Mitri | Neurology | Downey, CA | 1,166 | $33K |
| 10 | Rajesh Agarwal | Internal Medicine | Mayfield Heights, OH | 2,146 | $33K |
| 11 | Donald Ratchford | Family Practice | Cresson, PA | 454 | $32K |
| 12 | Andrew Graf | Internal Medicine | Plymouth Meeting, PA | 1,843 | $32K |
| 13 | Luis Gaitan | Neurology | Brownsville, TX | 1,455 | $32K |
| 14 | Todd Fulcher | Family Practice | Jackson, MS | 3,464 | $31K |
| 15 | Alexander Frank | Family Practice | Oklahoma City, OK | 1,849 | $31K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 253 | Risdiplam (Evrysdi) | $51.1M | 1,891 |
| 254 | Amikacin Liposomal/Neb.Accessr (Arikayce) | $50.5M | 3,394 |
| 255 | Diclofenac Epolamine (Licart) | $50.5M | 72,299 |
| 256 | Donepezil Hcl (Donepezil Hcl) | $50.3M | 3,178,215 |
| 257 | Paliperidone (Paliperidone Er) | $49.3M | 129,516 |
| 258 | Sucralfate (Sucralfate) | $48.5M | 689,007 |
| 259 | Diroximel Fumarate (Vumerity) | $48.5M | 5,351 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology